Article
Hormone replacement therapy, family history, and breast cancer risk among postmenopausal women.
Epidemiology (Cambridge, Mass.) - 1 Sept 2009
Gramling Robert, Eaton Charles B, Rothman Kenneth J, Cabral Howard, Silliman Rebecca A, Lash Timothy L
Abstract excerpt
BACKGROUND: Evidence is mixed regarding how familial predisposition to breast cancer affects the relation between hormone replacement therapy and risk of postmenopausal breast cancer. We investigated whether the risk difference for invasive breast cancer attributable to estrogen plus progesterone replacement therapy is greater among women with a first-degree family history of the disease. METHODS: This study is a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
